Ranbaxy Laboratories has received approval from Canadian authorities to sell Ran-Pravastatin, a cholesterol lowering drug, in Canada.
IVRCL Infrastructures & Projects has bagged irrigation projects worth Rs 551 crore from Andhra Pradesh Government.
Indian Equity Research and Investment Strategy
Ranbaxy Laboratories has received approval from Canadian authorities to sell Ran-Pravastatin, a cholesterol lowering drug, in Canada.
IVRCL Infrastructures & Projects has bagged irrigation projects worth Rs 551 crore from Andhra Pradesh Government.